-
Annexin V-PE Reagent for CD38 CAR-T Studies
2026-09-18
Connect CD38 CAR-binder design with a rapid phosphatidylserine readout using Annexin V-PE Reagent. The workflow supports parallel analysis of target-cell apoptosis, CAR-T fratricide, and assay quality by flow cytometry or fluorescence microscopy.
-
Tigecycline Workflows for MDR Bacterial Research
2026-09-17
Tigecycline is a glycylcycline antibiotic suited to standardized phenotypic testing across MRSA, GISA, and carbapenem-resistant Enterobacter cloacae research. This workflow-focused guide connects 30S ribosomal inhibition with plasmid-transmission studies, assay controls, and practical troubleshooting.
-
p-Cresyl Sulfate and Aortic Valve Calcification
2026-09-17
A 2026 study identifies p-cresyl sulfate as a direct enhancer of calcification in porcine aortic valvular interstitial cells and links this effect to HIF-1α activation, klotho loss, and NF-κB/RUNX2 signaling. The findings extend research on this protein-bound uremic toxin from vascular injury to calcific aortic valve disease and nominate klotho and SIRT1 as mechanistically relevant intervention points.
-
KCNE4-Dependent Modulation of Kv1.3 Pharmacology
2026-09-16
The reference study shows that KCNE4 changes the pharmacological behavior of Kv1.3 primarily by slowing intracellular Psora-4 inhibition rather than by substantially changing blocker affinity. This finding links auxiliary-subunit composition to assay kinetics and has practical implications for research on T cell Ca2+ signaling and immunomodulator targeting Kv1.3.
-
Ginsenoside Rg1 and the Gut–Brain Assay
2026-09-16
Ginsenoside Rg1 offers a mechanistically grounded way to study neuroimmune disruption after prolonged anesthesia. This guide translates Treg-dependent gut–immune–brain findings into practical assay, handling, and translational decision frameworks.
-
Sodium Oxamate: LDH-A Workflow for Metabolic Studies
2026-09-15
Sodium Oxamate provides a water-soluble, mechanism-oriented way to test whether LDH-A activity, lactate production, and glycolytic remodeling drive a phenotype. This workflow connects cancer metabolism research with a carefully bounded antiviral application while emphasizing controls that distinguish metabolic causality from nonspecific toxicity.
-
Fast-Dissociating Antibodies for Single-Molecule Imaging
2026-09-15
Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay to identify specific monoclonal antibodies that dissociate rapidly, directly from hybridoma cultures. The resulting Fab probes enabled multiplexed imaging and revealed rapid espin turnover within apparently stable F-actin cores of inner-ear stereocilia.
-
Mithramycin A Workflows for Cancer Research
2026-09-14
Mithramycin A converts metal-dependent binding to G-C-rich DNA into a practical perturbation strategy for transcription, c-myc regulation, and leukemia research. This workflow also shows how findings from a doxorubicin heart-failure study can inform assay design without overstating an unvalidated cardiac application.
-
LY2603618: Chk1 Inhibitor Workflow Guide
2026-09-14
LY2603618 provides a controllable way to study Chk1-dependent DNA damage tolerance, G2/M progression, and chemotherapy response. This workflow-focused guide connects concentration selection, phospho-H2AX, cell-cycle profiling, and combination testing while separating established product information from exploratory assay recommendations.
-
Oligo (dT) 25 Beads: Practical mRNA Workflow
2026-09-13
Oligo (dT) 25 Beads provide a magnetic capture route for isolating polyadenylated eukaryotic mRNA from total RNA, cells, or tissues. They are appropriate for animal and plant samples and downstream RT-PCR, cDNA synthesis, and sequencing workflows, but they should not be treated as a general method for recovering non-polyadenylated RNA.
-
PPP1R3G–PP1γ Control of RIPK1 Cell Death
2026-09-12
The reference study identifies PPP1R3G as a regulatory component that recruits PP1γ to TNF receptor complex I, enabling dephosphorylation and activation of RIPK1. Its genetic, biochemical, and mouse-model evidence connects phosphatase-directed control of RIPK1 to both RIPK1-dependent apoptosis and type I necroptosis, while also clarifying how inflammatory signaling can transition toward cell death.
-
CD38 CAR Binder Structures and Affinity Tuning
2026-09-11
Cheng et al. combine crystal structures, mutational mapping, biochemical assays, and CAR-T functional testing to show that CD38 binders RP02 and 028 engage distinct antigen surfaces and produce different effects on CD38 enzymatic activity. The affinity-attenuated 028R103G variant reduced CAR-T fratricide while preserving cytotoxicity against CD38-positive tumors, illustrating why CAR optimization must balance binding strength, epitope geometry, enzyme inhibition, and cellular selectivity.
-
Dehydroepiandrosterone (DHEA) Lab Workflows
2026-09-11
A scenario-based guide to using Dehydroepiandrosterone (DHEA), SKU B1375, in viability, proliferation, apoptosis, neural, and ovarian experiments. It addresses solvent control, concentration–time design, interpretation of DHEA-induced PCOS models, and practical vendor selection.
-
Cell Cycle Assay Kit: Decode Drug Response
2026-09-10
Discover how the Cell Cycle Assay Kit (K2263) converts DNA-content histograms into defensible evidence of cell-cycle arrest and apoptosis. Using GANT61-treated ALK-positive lymphoma as a mechanistic case study, this guide explains assay design, controls, interpretation, and limitations.
-
Cannabidiol in Orofacial Pain and Pain Affect
2026-09-10
A 2026 Brain Research Bulletin study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-related affective and cognitive deficits in mice. Its value lies in connecting peripheral CB2-linked anti-inflammatory effects with central CB1 and serotonergic mechanisms, while providing a multidimensional framework for preclinical pain research.